|Articles|July 23, 2015

Covance Co-Locates Facility for Increased Patient Exposure

LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.

LabCorp® announced that Covance Drug Development has relocated its clinical research unit  in Dallas, TX, to a new, fit-for-purpose clinical research facility.  This unit opened earlier this month and has expanded from 72 to 100 medical beds. In addition, a LabCorp patient service center will be co-located in the CRU, at which patients will have an opportunity to learn more about volunteering and participating in early stage clinical trials.
 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.